Spain May Set Further Restrictions on The Sale and Distribution of Vapes

RegulationsMarket
Jul.05.2022
The Ministry of Health is looking into banning online sales of vaping products, and limit sales to specialized tobacco shops.

The Royal Decree 579/2017, is the legislation pertaining to the manufacture, advertising and sale of vaping products in Spain. The decree basically translates the Tobacco Products Directive (TPD) into Spanish regulations, and has been effective since the 11th of June 2017.

Spain May Set Further Restrictions on The Sale and Distribution of Vapes

And now, says Euro Weekly, the Spanish Government has set out to put further restrictions on the sale and distribution of e-cigarettes, with the Ministry of Health saying that they aim to reformulate the local anti-smoking legislation and extend it to the use of e-cigarettes, as they cause “harmful short-term effects”.

 

Led by Carolina Darias, the ministry said they are concerned about the sale of the devices, as “there is a large number of websites where nicotine-based devices can be bought online, and the methods for preventing access to minors are neither sufficient nor effective.” To this effect, they are looking into banning online sales of vaping products, and limit sales to specialised tobacco shops.

 

A general e-liquid tax is proposed

 

Similarly last year, Spain’s Ministry of Finance said it wanted to tighten the tobacco regulatory framework, so as to be in line with WHO and EU TPD standards. The umbrella organisation- the National Committee for the Prevention of Smoking (Comité Nacional para la Prevención del Tabaquismo (CNPT) had prepared a report for the Ministry of Health suggesting an excise duty based on both volume of e-liquid and nicotine content.

 

The report proposed a general e-liquid tax at the EU average rate of €0.15 per ml, with an additional element for nicotine content at €0.006 per mg. The group said that with an average tax rate of 35.6%, the Spanish government could collect €35m in revenue a year from the tax. “This is a viable option for the Spanish economy,” said a CNPT spokesperson to ECigIntelligence. “The government would obtain an economic return, while at the same time promoting a reduction in the consumption of these products.”

 

Commenting on the proposed tax, ECigIntelligence has recently highlighted that if the Spanish government indeed agrees to the tax, the local vape industry would be deeply impacted. The agency believes that the CNPT’s proposal is currently being discussed internally between the Ministry of Health and the Ministry of Finance.

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Swedish Match Faces Broader Labeling Order After ZYN Inspection, Documents Obtained by 2Firsts Show
Documents obtained by 2Firsts show that Sweden's Public Health Agency ordered Swedish Match to revise ingredient labels beyond the five ZYN products inspected. The dispute centers on whether flavoring ingredients must be individually disclosed, with Swedish Match citing trade-secret protection and the regulator insisting on full ingredient disclosure. The company faces a conditional penalty of SEK 2 million per month for noncompliance. As of October 22, the agency had received no appeal, despite the company's stated intention to challenge the decision.
Oct.22
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23